Phase 1, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose Study to Evaluate the Effect on Blood Pressure of AMG 334 Given Concomitantly With Subcutaneous Sumatriptan (Imitrex) in Healthy Subjects
Latest Information Update: 16 Jan 2020
At a glance
- Drugs Erenumab (Primary) ; Sumatriptan
- Indications Migraine
- Focus Pharmacodynamics
- Sponsors Amgen
- 27 Jun 2017 Results presented at the 3rd Congress of the European Academy of Neurology
- 28 Apr 2017 Results assessing effect of sumatriptan alone and in combination with erenumab on resting blood pressure and results of post hoc analysis assessing change in MAP following erenumab and sumatriptan alone, presented at the 69th Annual Meeting of the American Academy of Neurology
- 09 Sep 2016 Status changed from active, no longer recruiting to completed.